ConductScience.org, home

Library / Trial comparisons

Digital Breast Tomosynthesis vs Digital Mammography: Number of Participants With Interval Breast Cancer

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.001390.0009010.00215wilsonClinicalTrials.gov
Risk in group 20.002020.001410.0029wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.000627-0.001630.000346newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.6890.391.22logClinicalTrials.gov
Odds ratio, group 1 over group 20.6890.3891.22logClinicalTrials.gov
Number needed to treat, for one fewer participant with the outcome on Digital Breast Tomosynthesis than on Digital Mammography1,590from the risk difference intervalthe interval includes no differenceClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Digital Breast Tomosynthesis
Digital Breast Tomosynthesis + Synthetic Mammography (DBT)~The DBT was independently read by two radiologists. A consensus meeting decided whether to recall the woman or not.~Women selected for further assessment (positive screening exam) was recalled.~Digital Breast Tomosynthesis + Synthetic Mammography: Two-view tomosynthesis performed with GE SenoClaire 3D Breast Tomosynthesis.
2014,380OG000ClinicalTrials.gov
Group 2Digital Mammography
The digital mammograms was independently read by two radiologists. A consensus meeting decided whether to recall the woman or not.~Women selected for further assessment (positive screening exam) was recalled.~Digital mammography: Two-view digital mammography performed with GE SenoClaire 3D Breast Tomosynthesis.
2914,369OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleNumber of Participants With Interval Breast CancerClinicalTrials.gov
DescriptionRate of interval breast cancer among those screened with tomosynthesis versus digital mammography as performed in a population based screening program.ClinicalTrials.gov
Time frame60 months from start up of the trialClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleThe Digital Breast Tomosynthesis Trial in BergenClinicalTrials.gov
NCT numberNCT02835625ClinicalTrials.gov
PhasesNAClinicalTrials.gov
ConditionsBreast NeoplasmsClinicalTrials.gov
InterventionsSynthetic Mammography + Digital Breast Tomosynthesis, Digital mammographyClinicalTrials.gov
Lead sponsorNorwegian Institute of Public HealthClinicalTrials.gov
Results first posted2021-01-15ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02835625?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.